Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

Pinzour doctors signed her up for a new kind of treatment. It uses the patient's own tumor-fighting T-cells, called tumor-infiltrating lymphocytes, or TILs. "By taking those TILs out of the ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

Genome-scale metabolic reconstruction of urinary microbiome: Pathway for personalized medicine. Frequency and impact of a genome-wide homologous recombination deficiency signature (HRDsig+) on the ...

The biotechnology company intends to more than double its current production capacity at the Navy Yard, interim CEO Fred Vogt ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You accept for the main domain ...

KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, including ...

(InvestigateTV) — While melanoma is not as common as other skin cancers, it’s often referred to as the most serious form. It develops when the cells that give the skin its tan or brown color start to ...

The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive ...

Iovance Biotherapeutics, Inc.’s IOVA share price has dipped by 19.49%, which has investors questioning if this is right time ...